Vascular subcortical syndrome of aging

Reviews in Clinical Gerontology

Volumn 14, Issue 4, 2004, Pages 269-282

  Fish, Mark ^a,b   Bayer, Antony ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN DISEASE; BRAIN FUNCTION; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DEPRESSION; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MEMORY DISORDER; MOOD; MOOD DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PERSONALITY DISORDER; POPULATION RESEARCH; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RISK FACTOR; SYMPTOM; SYNDROME; THINKING; WHITE MATTER;

EID: 30544450078     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259805001619     Document Type: Review

References (94)

1. de Leeuw FE, de Groot JC, Achten E et al. Prevalence of cerebral white matter lesions in elderly people: a population-based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9-14.
2. Carpenter M. Core Text of Neuroanatomy, fourth edition. Baltimore: Williams & Wilkins, 1991.
3. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord 1987; 2: 1-8.
4. de Groot JC, de Leeuw FE, Oudkerk M et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145-51.
5. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13: 266-71.
6. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873-80.
7. Schmidt WP, Roesler A, Kretzschmar K, Ladwig KH, Junker R, Berger K. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc 2004; 52: 1045-50.
8. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
9. Munoz DG. Histopathology. In: Bowler JV, Hachinski V, editors. Vascular cognitive impairment:preventable dementia. Oxford, New York: Oxford University Press, 2003: 57-75.
10. Sarti C, Pantoni L. Experimental models of vascular dementia: a focus on white matter disease and incomplete infarction. In: Bowler JV, Hachinski V, editors. Vascular cognitive impairment: preventable dementia. Oxford: Oxford University Press, 2003.
11. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Post-mortem pathological correlations. Stroke 1986; 17: 1090-07.
12. Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49: 747-52.
13. Munoz DG, Hastak SM, Harper B, Lee D, Hachinski VC. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging. Arch Neurol 1993; 50: 492-97.
14. Fazekas F, Kleinert R, Offenbacher H et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-89.
15. Critchley M. Arteriosclerotic pseudoparkinsonism. In: Rose F C, Capildeo R, eds. Research progress in Parkinson's disease. Pitman Medical, 1981.
16. Barber R, Scheltens P, Gholkar A et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66-72.
17. O'Brien J, Desmond P, Ames D, Schweitzer I, Harrigan S, Tress B. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996; 168: 477-85.
18. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154: 497-501.
19. Wu CC, Mungas D, Petkov CI et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002; 59: 383-91.
20. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities on MRI in the neurologically non-diseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26: 1171-77.
21. Pohjasvaara T, Mantyla R, Salonen O et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000; 57: 1295-300.
22. Pohjasvaara T, Mantyla R, Aronen HJ et al. Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry 1999; 67: 742-48.
23. Henon H, Pasquier F, Durieu I et al. Pre-existing dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997; 28: 2429-36.
24. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Clinical features of MRI-defined subcortical vascular disease. Alzheimer Dis Assoc Disord 2003; 17: 236-42.
25. Longstreth WT, Jr., Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-82.
26. Nebes RD, Vora IJ, Meltzer CC et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry 2001; 158: 878-84.
27. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993; 50: 818-24.
28. Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berliner Klin Wochenschr 1894; 32: 1180-86.
29. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37: 121-30.
30. Erkinjuntti T, Inzitari D, Pantoni L et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23-30.
31. Erkinjuntti T, Inzitari D, Pantoni L et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann N Y Acad Sci 2000; 903: 262-72.
32. Román GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
33. Cannata AP, Alberoni M, Franceschi M, Mariani C. Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease. Dement Geriatr Cogn Disord 2002; 13: 101-11.
34. Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML. Frontal systems' impairment following multiple lacunar infarcts. Arch Neurol 1990; 47: 129-32.
35. Brown P, Marsden CD. What do the basal ganglia do? Lancet 1998; 351(9118): 1801-04.
36. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56: 98-102.
37. Zijlmans JC, Thijssen HO, Vogels OJ et al. MRI in patients with suspected vascular parkinsonism. Neurology 1995; 45: 2183-88.
38. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001; 104: 63-67.
39. Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004; 75: 545-47.
40. Guerini F, Frisoni GB, Bellwald C, Rossi R, Bellelli G, Trabucchi M. Subcortical vascular lesions predict functional recovery after rehabilitation in patients with L-dopa refractory parkinsonism. J Am Geriatr Soc 2004; 52: 252-56.
41. Hughes AJ. Clinicopathological aspects of Parkinson's disease. Eur Neurol 1997; 38 (suppl 2): 13-20.
42. Bower JH, Dickson DW, Taylor L, Maraganore DM, Rocca WA. Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord 2002; 17: 910-16.
43. Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004; 19: 630-40.
44. van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 1998; 13: 89-95.
45. Camicioli R, Moore MM, Sexton G, Howieson DB, Kaye JA. Age-related brain changes associated with motor function in healthy older people. J Am Geriatr Soc 1999; 47: 330-34.
46. Masdeu JC, Wolfson L, Lantos G et al. Brain white-matter changes in the elderly prone to falling. Arch Neurol 1989; 46: 1292-96.
47. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997; 45: 1434-38.
48. Camus V, Kraehenbuhl H, Preisig M, Bula CJ, Waeber G. Geriatric depression and vascular diseases: what are the links? J Affect Disord 2004; 81: 1-16.
49. Breitner JC. Vascular depression: new light on an established idea? J Neurol Neurosurg Psychiatry 2001; 70: 3.
50. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-12.
51. Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry 1997; 154: 4-17.
52. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol 1988; 45: 725-30.
53. Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Auerbach C, Patel M. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in Geriatric Depression. Stroke 1998; 29: 613-17.
54. Mast BT, Neufeld S, MacNeill SE, Lichtenberg PA. Longitudinal support for the relationship between vascular risk factors and late-life depressive symptoms. Am J Geriatr Psychiatry 2004; 12: 93-101.
55. Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990; 147: 187-89.
56. Van den Berg MD, Oldehinkel AJ, Bouhuys AL, Brilman EI, Beekman AT, Ormel J. Depression in later life: three etiologically different subgroups. J Affect Disord 2001; 65: 19-26.
57. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24: 1631-34.
58. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37: 151-60.
59. Simpson S, Baldwin RC, Jackson A, Burns A, Thomas P. Is the clinical expression of late-life depression influenced by brain changes? MRI subcortical neuroanatomical correlates of depressive symptoms. Int Psychogeriatr 2000; 12: 425-34.
60. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999; 30: 2159-66.
61. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML. Clinical presentation of the 'depression-executive dysfunction syndrome' of late life. Am J Geriatr Psychiatry 2002; 10: 98-106.
62. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically-defined vascular depression. Am J Psychiatry 1997; 154: 562-65.
63. Alexopoulos GS. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry 2002; 10: 687-95.
64. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999; 56: 713-18.
65. Cervilla J, Prince M, Rabe-Hesketh S. Vascular disease risk factors as determinants of incident depressive symptoms: a prospective community-based study. Psychol Med 2004; 34: 635-41.
66. Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int J Geriatr Psychiatry 2001; 16: 718-27.
67. Hickie I, Scott E, Wilhelm K, Brodaty H. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - a longitudinal evaluation. Biol Psychiatry 1997; 42: 367-74.
68. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 74-53.
69. Ballard C, McKeith I, O'Brien J et al. Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 2000; 11: 59-65.
70. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Jama 1997; 277: 813-17.
71. van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004; 62: 1862-64.
72. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med 2002; 347: 1761-68.
73. Merello M, Sabe L, Teson A, Migliorelli R et al. Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1994; 57: 1503-09.
74. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol 2003; 60: 539-44.
75. Simpson S, Allen H, Tomenson B, Burns A. Neurological correlates of depressive symptoms in Alzheimer's disease and vascular dementia. J Affect Disord 1999; 53: 129-36.
76. Dubinsky RM, Jankovic J. Progressive supranuclear palsy and a multi-infarct state. Neurology 1987; 37: 570-76.
77. Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 1995; 273: 1348-53.
78. Brown JS, Vittinghoff E, Wyman JF et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000; 48: 721-25.
79. Wolf SL, Riolo L, Ouslander JG. Urge incontinence and the risk of falling in older women. J Am Geriatr Soc 2000; 48: 847-48.
80. Biderman A, Cwikel J, Fried AV, Galinsky D. Depression and falls among community-dwelling elderly people: a search for common risk factors. J Epidemiol Community Health 2002; 56: 631-36.
81. Rosano C, Simonsick EM, Harris TB et al. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 2005; 24: 8-14.
82. Mast BT, Yochim B, MacNeill SE, Lichtenberg PA. Risk factors for geriatric depression: the importance of executive functioning within the vascular depression hypothesis. J Gerontol A Biol Sci Med Sci 2004; 59: 1290-94.
83. de Leeuw FE, de Groot JC, Oudkerk M et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125(Pt 4): 765-72.
84. de Leeuw FE, de Groot JC, Oudkerk M et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 2000; 54: 1795-801.
85. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol 2000; 57: 1422-27.
86. Tanizaki Y, Kiyohara Y, Kato I et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000; 31: 2616-22.
87. Petty GW, Brown RD, Jr., Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999; 30: 2513-16.
88. Kaul S, Venketswamy P, Meena AK, Sahay R, Murthy JM. Frequency, clinical features and risk factors of lacunar infarction (data from a stroke registry in South India). Neurol India 2000; 48: 116-19.
89. Takami S, Imai Y, Katsuya T et al. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study. Am J Hypertens 2000; 13: 121-27.
90. Schmidt R, Schmidt H, Fazekas F et al. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension 2001; 38: 110-15.
91. Artero S, Tiemeier H, Prins ND, Sabatier R, Breteler MM, Ritchie K. Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry 2004; 75: 1304-08.
92. Pugh KG, Lipsitz LA. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002; 23: 421-31.
93. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (DSM-IV), fourth edition. Washington, DC: American Psychiatric Association.
94. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's. Disease Diagnostic and Treatment Centers. Neurology 1992; 42 (3 Pt. 1): 473-80.